 | • レポートコード：QYR2104Z4831 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、前立腺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ザイティガ、ゴナックス、リュープリン、ゾラデックス、デカペプチル、エリガード、Vantas、カソデックス、その他）、用途別市場規模（病院、外来手術センター、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・前立腺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・前立腺がん治療薬の種類別市場規模（ザイティガ、ゴナックス、リュープリン、ゾラデックス、デカペプチル、エリガード、Vantas、カソデックス、その他） ・前立腺がん治療薬の用途別市場規模（病院、外来手術センター、クリニック） ・前立腺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・前立腺がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Astella、Sanofi、Ipsen、Bayer、AstraZeneca、Dendreon） ・結論 |
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
Market Analysis and Insights: Global Prostate Cancer Treatment Drugs Market
The global Prostate Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Treatment Drugs market.
Global Prostate Cancer Treatment Drugs Scope and Market Size
Prostate Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Zytiga
1.2.3 Gonax
1.2.4 Lupron
1.2.5 Zoladex
1.2.6 Decapeptyl
1.2.7 Eligard
1.2.8 Vantas
1.2.9 Casodex
1.2.10 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Treatment Drugs Market Perspective (2016-2027)
2.2 Prostate Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Prostate Cancer Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Treatment Drugs Industry Dynamic
2.3.1 Prostate Cancer Treatment Drugs Market Trends
2.3.2 Prostate Cancer Treatment Drugs Market Drivers
2.3.3 Prostate Cancer Treatment Drugs Market Challenges
2.3.4 Prostate Cancer Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Prostate Cancer Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Treatment Drugs Revenue
3.4 Global Prostate Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Prostate Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Drugs Revenue in 2020
3.5 Prostate Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Prostate Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Prostate Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Prostate Cancer Treatment Drugs Market Size (2016-2027)
6.2 North America Prostate Cancer Treatment Drugs Market Size by Type
6.2.1 North America Prostate Cancer Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Treatment Drugs Market Size by Application
6.3.1 North America Prostate Cancer Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Treatment Drugs Market Size by Country
6.4.1 North America Prostate Cancer Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Prostate Cancer Treatment Drugs Market Size (2016-2027)
7.2 Europe Prostate Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Prostate Cancer Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Prostate Cancer Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Prostate Cancer Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Treatment Drugs Market Size (2016-2027)
9.2 Latin America Prostate Cancer Treatment Drugs Market Size by Type
9.2.1 Latin America Prostate Cancer Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Treatment Drugs Market Size by Application
9.3.1 Latin America Prostate Cancer Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Treatment Drugs Market Size by Country
9.4.1 Latin America Prostate Cancer Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Astella
11.2.1 Astella Company Details
11.2.2 Astella Business Overview
11.2.3 Astella Prostate Cancer Treatment Drugs Introduction
11.2.4 Astella Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.2.5 Astella Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Prostate Cancer Treatment Drugs Introduction
11.3.4 Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Ipsen
11.4.1 Ipsen Company Details
11.4.2 Ipsen Business Overview
11.4.3 Ipsen Prostate Cancer Treatment Drugs Introduction
11.4.4 Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.4.5 Ipsen Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prostate Cancer Treatment Drugs Introduction
11.5.4 Bayer Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Treatment Drugs Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Dendreon
11.7.1 Dendreon Company Details
11.7.2 Dendreon Business Overview
11.7.3 Dendreon Prostate Cancer Treatment Drugs Introduction
11.7.4 Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2016-2021)
11.7.5 Dendreon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Zytiga
Table 3. Key Players of Gonax
Table 4. Key Players of Lupron
Table 5. Key Players of Zoladex
Table 6. Key Players of Decapeptyl
Table 7. Key Players of Eligard
Table 8. Key Players of Vantas
Table 9. Key Players of Casodex
Table 10. Key Players of Others
Table 11. Global Prostate Cancer Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Prostate Cancer Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Prostate Cancer Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Prostate Cancer Treatment Drugs Market Share by Regions (2016-2021)
Table 15. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Prostate Cancer Treatment Drugs Market Share by Regions (2022-2027)
Table 17. Prostate Cancer Treatment Drugs Market Trends
Table 18. Prostate Cancer Treatment Drugs Market Drivers
Table 19. Prostate Cancer Treatment Drugs Market Challenges
Table 20. Prostate Cancer Treatment Drugs Market Restraints
Table 21. Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Prostate Cancer Treatment Drugs Market Share by Players (2016-2021)
Table 23. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment Drugs as of 2020)
Table 24. Ranking of Global Top Prostate Cancer Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Prostate Cancer Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Prostate Cancer Treatment Drugs Product Solution and Service
Table 28. Date of Enter into Prostate Cancer Treatment Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 32. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Prostate Cancer Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 36. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Prostate Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Prostate Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Prostate Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Prostate Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Prostate Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Prostate Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Prostate Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Prostate Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Prostate Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Prostate Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Prostate Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Prostate Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Prostate Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Prostate Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Prostate Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Prostate Cancer Treatment Drugs Product
Table 71. Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Astella Company Details
Table 74. Astella Business Overview
Table 75. Astella Prostate Cancer Treatment Drugs Product
Table 76. Astella Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. Astella Recent Development
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Prostate Cancer Treatment Drugs Product
Table 81. Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Ipsen Company Details
Table 84. Ipsen Business Overview
Table 85. Ipsen Prostate Cancer Treatment Drugs Product
Table 86. Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Ipsen Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Prostate Cancer Treatment Drugs Product
Table 91. Bayer Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Prostate Cancer Treatment Drugs Product
Table 96. AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Dendreon Company Details
Table 99. Dendreon Business Overview
Table 100. Dendreon Prostate Cancer Treatment Drugs Product
Table 101. Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 102. Dendreon Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Zytiga Features
Figure 3. Gonax Features
Figure 4. Lupron Features
Figure 5. Zoladex Features
Figure 6. Decapeptyl Features
Figure 7. Eligard Features
Figure 8. Vantas Features
Figure 9. Casodex Features
Figure 10. Others Features
Figure 11. Global Prostate Cancer Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 12. Hospitals Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Clinics Case Studies
Figure 15. Prostate Cancer Treatment Drugs Report Years Considered
Figure 16. Global Prostate Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Prostate Cancer Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Prostate Cancer Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 19. Global Prostate Cancer Treatment Drugs Market Share by Regions (2022-2027)
Figure 20. Global Prostate Cancer Treatment Drugs Market Share by Players in 2020
Figure 21. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment Drugs as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2020
Figure 23. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 25. North America Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Prostate Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 27. North America Prostate Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 28. North America Prostate Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 29. United States Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Prostate Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 33. Europe Prostate Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 34. Europe Prostate Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 35. Germany Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Prostate Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Prostate Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Prostate Cancer Treatment Drugs Market Share by Region (2016-2027)
Figure 45. China Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Prostate Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 53. Latin America Prostate Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 54. Latin America Prostate Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 55. Mexico Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Prostate Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Prostate Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Prostate Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 61. Turkey Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Prostate Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 65. Astella Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 67. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 70. Dendreon Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed